Skip to content
Screener

Cushman & Wakefield CWK Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Jones Lang LaSalle logo
Jones Lang LaSalleJLL
$119.7M-2.6%
The RMR Group logo
The RMR GroupRMR
$174.38M-2.0%
Newmark Group, Inc. logo
Newmark Group, Inc.NMRK
$302.28M+29.4%
CoStar Group logo
CoStar GroupCSGP
$13M
Centerspace logo
CenterspaceCSR
$115.17M
Healthcare Realty Trust logo
Healthcare Realty TrustHR
$54.5M-14.8%

Other financials

Income statement

See full
Revenue$2.8B+11.2%
Gross profit$512.0M+9.6%
Operating income$134.2M+9.3%
Net income$52.7M-8.0%
EPS (diluted)$0.22-12.0%

Balance sheet

See full
Cash & equivalents$518.7M-19.7%
Total debt$3.1B-5.9%
Total equity$2.0B+6.2%
Total assets$7.6B0.0%

Cash flow

See full
Operating cash flow-$243.5M-50.3%
CapEx$8.5M-8.6%
Free cash flow-$255.7M-53.5%

Valuation

See full
Market cap$3.25B+3.9%
Enterprise value$5.8B+1.0%
P/E21.8×
P/S0.3×0.0×

Profitability

See full
Gross margin18.1%-0.5pp
Operating margin4.4%+0.1pp
Net margin2.2%
FCF margin1.9%+0.5pp

Returns & leverage

See full
Return on equity12.2%
Debt / equity1.5×-0.2×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Cushman & Wakefield in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Cushman & Wakefield’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628369-26-000118
(in millions, except share data) / AssetsAs of / June 30, 2026 / (unaudited)As of / December 31, 2025
Common shares, par value $0.10 per share, 800,000,000 shares authorized; 234,498,592 and 231,699,585 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively23.423.2
Additional paid-in capital3,045.03,038.4
Accumulated deficit(857.6)(897.7)
Accumulated other comprehensive loss(189.1)(208.6)
Total equity attributable to the Company2,021.71,955.3
Non-controlling interests0.40.5
Total equity2,022.11,955.8
Total liabilities and shareholders’ equity$7,553.7$7,676.6

Item 1. Financial Statements.

FAQ

What is Cushman & Wakefield's noncontrolling interests in subsidiaries?
Cushman & Wakefield (CWK) reported noncontrolling interests in subsidiaries of $400K in Q2 2026.
How has Cushman & Wakefield's noncontrolling interests in subsidiaries changed year-over-year?
Cushman & Wakefield's noncontrolling interests in subsidiaries decreased by 33.3% year-over-year, from $600K to $400K.
What is the long-term trend for Cushman & Wakefield's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Cushman & Wakefield's noncontrolling interests in subsidiaries has grown at a -11.1% compound annual growth rate (CAGR), from $900K to $500K.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Cushman & Wakefield's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude